Bernard Ashby, MD
NPI 1679732622ActiveIndividual· Internal Medicine, Cardiovascular Disease· Miami, FL
Internal Medicine, Cardiovascular Disease (MD) in Miami, Florida, licensed in FL, with an NPI issued in June 2008. Their prescriptions cost Medicare Part D more than their services did: $248,100 for 667 claims, against $21,770 paid for services in 2024. Glaxosmithkline, LLC. was the largest of 5 companies reporting payments in 2025, $72,053 in all, mostly consulting fees.
Overview
| NPI | 1679732622 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Jun 5, 2008 |
| Last updated in NPPES | Jan 29, 2026 |
| Certified by provider | Jan 29, 2026 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Cardiovascular Disease Primary | 207RC0000X | ME120798 | FL |
| Internal Medicine | 207R00000X | ME120798 | FL |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Cardiovascular Disease (Cardiology) (FL) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 27 |
|---|---|
| Services billed | 180 across 15 procedure codes |
| Paid by Medicare | $21,770 |
Part D prescriptions in 2024
| Prescriptions (claims) | 667 · 1,494 30-day fills |
|---|---|
| Patients | 60 |
| Total drug cost | $248,100 |
| Generic share | 64% of claims |
Education and affiliations
| Graduation year | 2007 |
|---|---|
| Medicare specialty | Cardiovascular Disease (Cardiology) |
Industry payments (Open Payments)
- 2025$72,053 · 32 payments from 5 companies
- 2024$34,370 · 32 payments from 6 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Glaxosmithkline, LLC. | $40,707 | 10 |
| Novo Nordisk Inc | $31,271 | 19 |
| Actelion Pharmaceuticals US, Inc. | $30.00 | 1 |
| Astrazeneca Pharmaceuticals LP | $23.24 | 1 |
| Abbott Laboratories | $21.31 | 1 |
What the 2025 payments were for
- Consulting Fee$39,100 · 6 payments
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$24,992 · 4 payments
- Travel and Lodging$7,229 · 13 payments
- Food and Beverage$730.87 · 9 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Cardiovascular Disease providers in Miami
- 1326278359
- 1629243563
- 1639333735
- 1700194511
- 1659792646
- 1457362733
- 1487043436
- 1487926614
- 1053505255
- 1831123520
- 1215296199
- 1538358494
All Internal Medicine, Cardiovascular Disease providers in Florida →